Trial Design
This single-center, double-blind, midazolam-controlled randomized clinical trial was conducted at Beijing Anding Hospital, Capital Medical University, Beijing, China, and approved by a local independent ethics committee. All participants provided their written informed consent. This study followed the Consolidated Standards of Reporting Trials (